Central Florida Inpatient Medicine, Inc.

Central Florida Inpatient Medicine (CFIM) provides specialized hospitalist services to improve patient care during hospital stays, focusing on comprehensive medical care and innovative health management solutions. Central Florida Inpatient Medicine, Inc. is based in Lake Mary, US, and was founded in 2001. The company specializes in hospital medicine and has undergone a significant transformation in its business operations.

Krishan Nagda serves as the CEO. In March 2017, CFIM was acquired by Spectrum Medical Partners, a portfolio company of HealthEdge Investment Partners, although financial terms were not disclosed. CFIM has executed one deal since its inception, with its most recent deal occurring in March 2017. Central Florida Inpatient Medicine (CFIM) specializes in hospital medicine, offering a comprehensive suite of services aimed at enhancing patient care during hospital stays.

CFIM's core offerings include inpatient medical care, population health management, and the development of proprietary communication technologies designed to support both acute and post-acute patient journeys. These services cater to a diverse clientele including hospitals, healthcare systems, and individual patients across Florida and surrounding regions. By prioritizing personalized care and patient education, CFIM addresses critical challenges in hospital medicine, ensuring high-quality care for patients navigating their treatment processes. Central Florida Inpatient Medicine's revenue model revolves around agreements with hospitals and healthcare systems, emphasizing partnerships that facilitate the delivery of hospitalist services.

CFIM collaborates with healthcare facilities on a business-to-business basis, providing comprehensive inpatient medical care through service contracts. These agreements may include specifics on staffing arrangements and shared responsibilities, with contracted fees for hospitalist coverage varying based on patient volume and care levels required. CFIM's focus on quality, value-based care positions it favorably within the industry, striving to deliver efficient healthcare solutions to its partners and communities. Central Florida Inpatient Medicine plans to expand its service offerings and geographic reach in the upcoming years.

The company is expected to develop new products aimed at enhancing patient care and may target expansion into additional markets beyond Florida. The recent acquisition by Spectrum Medical Partners may facilitate these strategic initiatives. The funding acquired during the acquisition will likely support CFIM’s plans for innovation and expansion, aligning with its commitment to improve healthcare delivery.